Research / HPTN 084
HPTN 084
Pediatric HIV
Follow-UpOn-Going
HPTN 084: Phase III Double Blind Safety and Efficacy Study of Long Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women
Pediatric HIV